Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Netherlands
  4. Euronext Amsterdam
  5. Royal DSM N.V.
  6. News
  7. Summary
    DSM   NL0000009827

ROYAL DSM N.V.

(DSM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Royal DSM N : DSM provides Q1 2021 trading update

05/05/2021 | 01:07am EDT

For the full year, DSM continues to expect an Adjusted EBITDA increase in Nutrition at the upper end of its mid-term strategic ambition of high single digit growth. Together with a stronger recovery in Materials than foreseen at the FY 2020 results release, DSM now expects an Adjusted EBITDA growth rate for the Group moving towards the mid-teens, with a continued good Adjusted Net Operating Free Cash Flow.

1) Adjusted EBITDA is an Alternative Performance Measure (APM) that reflects results from usual operations. Organic sales growth is the total impact of volume and price/mix. Adjusted Net Operating Free Cash Flow is the cash flow from operating activities, corrected for the cash flow of the APM adjustments, minus the cash flow of capital expenditures and drawing rights.

2) Results and KPIs throughout this document reflect continued operations, excluding the Resins & Functional Materials and associated businesses which were classified as 'held for sale' in September 2020. The sale was finalized on 1 April 2021.

The complete version of this press release can be found here.

Disclaimer

Koninklijke DSM NV published this content on 05 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 05 May 2021 05:06:01 UTC.


ę Publicnow 2021
All news about ROYAL DSM N.V.
05/11ROYAL DSM Ná : DSM - repurchase of shares (3-7 May 2021)
PU
05/10KONINKLIJKE DSM N.V. : Ex-dividend day for final dividend (optional)
FA
05/07ROYAL DSM Ná : Dutch PPE Solutions starts large-scale production of filter mater..
PU
05/06ROYAL DSM Ná : Annual General Meeting of Shareholders 2021
PU
05/06ROYAL DSM Ná : Final dividend 2020 Royal DSM
PU
05/06ROYAL DSM Ná : DSM announces results of 2021 Annual General Meeting of Sharehold..
PU
05/06ROYAL DSM N.V.á : Proxy Statments
CO
05/06ROYAL DSM N.V.á : Dividends
CO
05/05ROYAL DSM Ná : DSM lifts 2021 outlook as industrial materials demand recovers
RE
05/05ROYAL DSM Ná : DSM Sales Climb in Q1 As Materials Segment Recovers
MT
More news
Financials
Sales 2021 8 717 M 10 587 M 10 587 M
Net income 2021 937 M 1 138 M 1 138 M
Net Debt 2021 1 231 M 1 495 M 1 495 M
P/E ratio 2021 26,0x
Yield 2021 1,74%
Capitalization 25 480 M 30 926 M 30 946 M
EV / Sales 2021 3,06x
EV / Sales 2022 2,86x
Nbr of Employees 21 313
Free-Float 91,1%
Chart ROYAL DSM N.V.
Duration : Period :
Royal DSM N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ROYAL DSM N.V.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 153,38 €
Last Close Price 147,95 €
Spread / Highest target 21,7%
Spread / Average Target 3,67%
Spread / Lowest Target -47,3%
EPS Revisions
Managers and Directors
NameTitle
Dimitri de Vreeze Co-Chief Executive Officer & COO
GÚraldine Matchett Co-Chief Executive Officer & CFO
Robert John Routs Chairman-Supervisory Board
Pauline F. M. van der Meer Mohr Deputy Chairman
Eileen A. Kennedy Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
ROYAL DSM N.V.5.08%30 647
BASF SE6.47%76 412
SHIN-ETSU CHEMICAL CO., LTD.-0.11%66 524
DUPONT DE NEMOURS, INC.14.78%43 433
EVONIK INDUSTRIES AG10.19%16 540
ASAHI KASEI CORPORATION15.84%15 365